Vanda Pharmaceuticals Inc. - stock earnings
VNDA Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 1, 2024 AfterMarket | - / 0.0510000000 | - | - / 49.5 million | - |
VNDA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -2.4 million USD | 45.3 million USD |
| 2023Q3 | 137000 USD | 38.8 million USD |
| 2023Q2 | 1.5 million USD | 46.1 million USD |
| 2023Q1 | 3.3 million USD | 62.5 million USD |
| 2022Q4 | 6.9 million USD | 64.5 million USD |
| 2022Q3 | 3.3 million USD | 65.3 million USD |
| 2022Q2 | 2.6 million USD | 64.4 million USD |
| 2022Q1 | -6.4 million USD | 60.2 million USD |
| 2021Q4 | 7.1 million USD | 68.0 million USD |
| 2021Q3 | 7.8 million USD | 70.1 million USD |
| 2021Q2 | 9.7 million USD | 67.9 million USD |
| 2021Q1 | 8.7 million USD | 62.7 million USD |
| 2020Q4 | 8.2 million USD | 67.7 million USD |
| 2020Q3 | 5.9 million USD | 60.3 million USD |
| 2020Q2 | 8.7 million USD | 62.2 million USD |
| 2020Q1 | 486000 USD | 58.0 million USD |
| 2019Q4 | 4.2 million USD | 60.9 million USD |
| 2019Q3 | 100.4 million USD | 59.5 million USD |
| 2019Q2 | 11.5 million USD | 59.1 million USD |
| 2019Q1 | -612000 USD | 47.7 million USD |
| 2018Q4 | 10.4 million USD | 53.0 million USD |
| 2018Q3 | 7.2 million USD | 49.1 million USD |
| 2018Q2 | 4.6 million USD | 47.4 million USD |
| 2018Q1 | 3.1 million USD | 43.6 million USD |
| 2017Q4 | -1.8 million USD | 44.3 million USD |
| 2017Q3 | -4.6 million USD | 41.3 million USD |
| 2017Q2 | -1.5 million USD | 42.1 million USD |
| 2017Q1 | -7.6 million USD | 37.4 million USD |
| 2016Q4 | -604000 USD | 38.2 million USD |
| 2016Q3 | -430000 USD | 38.5 million USD |
| 2016Q2 | -4.6 million USD | 36.0 million USD |
| 2016Q1 | -12.4 million USD | 33.3 million USD |
| 2015Q4 | -14.8 million USD | 31.8 million USD |
| 2015Q3 | -9.5 million USD | 28.3 million USD |
| 2015Q2 | -5.4 million USD | 27.6 million USD |
| 2015Q1 | -10.2 million USD | 22.2 million USD |
| 2014Q4 | 69.7 million USD | 15.4 million USD |
| 2014Q3 | -1.4 million USD | 14.8 million USD |
| 2014Q2 | -21.6 million USD | 10.9 million USD |
| 2014Q1 | -26.5 million USD | 9.1 million USD |
| 2013Q4 | -7.6 million USD | 8.8 million USD |
| 2013Q3 | -5.4 million USD | 8.7 million USD |
| 2013Q2 | -3.1 million USD | 8.3 million USD |
| 2013Q1 | -4.2 million USD | 8.1 million USD |
| 2012Q4 | -6.4 million USD | 7.9 million USD |
| 2012Q3 | -5.3 million USD | 8.3 million USD |
| 2012Q2 | -8.0 million USD | 8.4 million USD |
| 2012Q1 | -8.0 million USD | 8.1 million USD |
| 2011Q4 | -5.5 million USD | 8.4 million USD |
| 2011Q3 | -3.1 million USD | 8.0 million USD |
| 2011Q2 | -1.3 million USD | 7.4 million USD |
| 2011Q1 | 136000 USD | 7.5 million USD |
| 2010Q4 | 2.2 million USD | 7.8 million USD |
| 2010Q3 | 3.2 million USD | 7.2 million USD |
| 2010Q2 | 1.3 million USD | 8.3 million USD |
| 2010Q1 | 529365 USD | 12.4 million USD |
| 2009Q4 | -9.2 million USD | 4.5 million USD |
| 2009Q3 | -7.7 million USD | ? USD |
| 2009Q2 | -12.4 million USD | ? USD |
| 2009Q1 | -6.5 million USD | ? USD |
| 2008Q4 | -7.5 million USD | ? USD |
| 2008Q3 | -10.9 million USD | ? USD |
| 2008Q2 | -13.5 million USD | ? USD |
| 2008Q1 | -19.2 million USD | 3.5 million USD |
| 2007Q4 | -20.7 million USD | ? USD |
| 2007Q3 | -21.9 million USD | ? USD |
| 2007Q2 | -16.0 million USD | ? USD |
| 2007Q1 | -15.4 million USD | ? USD |
| 2006Q4 | -11.9 million USD | ? USD |
| 2006Q3 | -12.1 million USD | ? USD |
| 2006Q2 | -21.4 million USD | ? USD |
| 2006Q1 | -18.1 million USD | ? USD |
| 2005Q4 | -6.8 million USD | ? USD |
| 2005Q3 | -5.7 million USD | ? USD |
| 2005Q2 | -5.5 million USD | ? USD |
| 2005Q1 | -5.9 million USD | ? USD |
| 2004Q4 | ? USD | 34000 USD |
VNDA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 2.5 million USD | 192.6 million USD |
| 2022 | 6.3 million USD | 254.4 million USD |
| 2021 | 33.2 million USD | 268.7 million USD |
| 2020 | 23.3 million USD | 248.2 million USD |
| 2019 | 115.6 million USD | 227.2 million USD |
| 2018 | 25.2 million USD | 193.1 million USD |
| 2017 | -15.6 million USD | 165.1 million USD |
| 2016 | -18.0 million USD | 146.0 million USD |
| 2015 | -39.9 million USD | 109.9 million USD |
| 2014 | 20.2 million USD | 50.2 million USD |
| 2013 | -20.3 million USD | 33.9 million USD |
| 2012 | -27.7 million USD | 32.7 million USD |
| 2011 | -9.8 million USD | 31.3 million USD |
| 2010 | 7.2 million USD | 35.2 million USD |
| 2009 | -35.9 million USD | 4.5 million USD |
| 2008 | -51.1 million USD | ? USD |
| 2007 | -74.1 million USD | ? USD |
| 2006 | -63.5 million USD | ? USD |
| 2005 | -23.9 million USD | ? USD |
| 2004 | -9.5 million USD | 33980 USD |
VNDA
Price: $4.68
52 week price:
Earnings Per Share: 0.04 USD
P/E Ratio: 16.52
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 456204
Ebitda: -1.4 millionMarket Capitalization: 259.5 million